{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:02:55Z","timestamp":1698598975608},"reference-count":41,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":8152,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1990,4]]},"abstract":"<jats:p>1. The phenotyping parameters for dextromethorphan and mephenytoin were assessed in 48 normal male volunteers following administration of each metabolic probe drug on separate occasions and together according to a randomized 3\u2010way crossover design. 2. Neither the urinary S\u2010\/R\u2010 mephenytoin ratio nor the dextromethorphan metabolic ratio were altered significantly by coadministration of the probe drugs. 3. Five\u2010hundred and nineteen subjects were screened for expression of mephenytoin 4\u2010 hydroxylase and dextromethorphan O\u2010demethylase activity following the coadministration of mephenytoin and dextromethorphan. The activity was determined in each case by methods not requiring any quantitative measurements. 4. Nineteen (3.7%) of the subjects were identified as poor metabolizers (PMs) of mephenytoin and 35 subjects (6.7%) as PMs of dextromethorphan. 5. All PMs of dextromethorphan were confirmed by more rigorous evaluation of the metabolic ratio.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1990.tb03653.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:20:32Z","timestamp":1343348432000},"page":"373-380","source":"Crossref","is-referenced-by-count":25,"title":["Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism."],"prefix":"10.1111","volume":"29","author":[{"given":"RJ","family":"Guttendorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Britto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RA","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TS","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KA","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Wedlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/312169a0"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(88)90146-5"},{"key":"e_1_2_1_4_1","first-page":"478P","article-title":"Poor metabolizer incidence of sparteine, mephenytoin and nifedipine in a Dutch population as assessed by a \u201ccocktail\u201d approach","volume":"89","author":"Breimer D. D.","year":"1986","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_5_1","first-page":"A135","article-title":"Polymorphisms in oxidative drug metabolism: relationship to food preference","volume":"3","author":"Britto M.","year":"1989","journal-title":"FASEB J."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1985.tb00058.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01453.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03426.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198903000-00016"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03075.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00562059"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.17.2.102"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(87)80252-8"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)90027-2"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258609050245"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198804000-00021"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.36"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.238"},{"key":"e_1_2_1_19_1","first-page":"443","article-title":"In vitro inhibition studies of two isozymes of human liver cytochrome P\u2010450, mephenytoin p\u2010hydroxylase and sparteine monooxygenase","volume":"13","author":"Inaba T.","year":"1985","journal-title":"Drug Metab. Disp."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb03284.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.113"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609247"},{"key":"e_1_2_1_23_1","first-page":"5488","article-title":"Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors","volume":"47","author":"Kaisary A.","year":"1987","journal-title":"Cancer Res."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258609050246"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90006-6"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541938"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03230.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258609050251"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05354.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.194"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92081-6"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.63"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01960741"},{"key":"e_1_2_1_34_1","first-page":"638","article-title":"Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a \u201ccocktail\u201d study design","volume":"249","author":"Schellens J. H. M.","year":"1989","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.235"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6312.295"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.4.785"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.3.751"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.176"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.11"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.256"},{"key":"e_1_2_1_42_1","first-page":"662","article-title":"Phenotypic differences in mephenytoin pharmacokinetics in normal subjects","volume":"23","author":"Wedlund P. J.","year":"1985","journal-title":"J. Pharmac. exp. Ther."}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1990.tb03653.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1990.tb03653.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T10:17:46Z","timestamp":1697969866000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1990.tb03653.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["10.1111\/j.1365-2125.1990.tb03653.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb03653.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}